Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

Authors :: G. Composto
P. Montemaggi
G. Mortellaro
P. Guerrieri
Sergio Rizzo
S. Russo
Dario Piazza
Ignazio Carreca
P MONTEMAGGI
P GUERRIERI
G MORTELLARO
G COMPOSTO
S RUSSO
D PIAZZA
S RIZZO
CARRECA I
Source :: Journal of Clinical Oncology. 23:1578-1578
Publication Year :: 2005
Publisher :: American Society of Clinical Oncology (ASCO), 2005.
Abstract: 1578 Background: Temozolomide (TMZ) is an oral alkylating agent known to cross the blood-brain barrier with efficacy against HGG and a favourable safety profile compared to conventional chemotherap...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Schedule
Temozolomide
Settore MED/06 - Oncologia Medica
business.industry
Newly diagnosed
Surgery
Safety profile
Internal medicine
medicine
business
medicine.drug
Radio chemotherapy

Tools